Glassman Wealth Services Global Blood Therapeutics, Inc. Transaction History

Glassman Wealth Services

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$22.3 - $37.39 $156 - $261	-7 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$25.48 - $37.34 $2,777 - $4,070	-109 Reduced 93.97%	7 $0
Q2 2021 Aug 04, 2021	BUY	$32.46 - $43.42 $3,603 - $4,819	111 Added 2220.0%	116 $4,000
Q4 2020 Feb 04, 2021	SELL	$37.65 - $63.77 $1,167 - $1,976	-31 Reduced 86.11%	5 $0
Q3 2020 Nov 09, 2020	BUY	$52.76 - $74.49 $580 - $819	11 Added 44.0%	36 $2,000
Q4 2019 Feb 07, 2020	BUY	$45.7 - $81.86 $45 - $81	1 Added 4.17%	25 $2,000
Q2 2019 Aug 08, 2019	BUY	$52.6 - $63.29 $210 - $253	4 Added 20.0%	24 $1,000
Q1 2019 May 10, 2019	BUY	$39.99 - $53.48 $799 - $1,069	20 New	20 $1,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.